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Edited by Ulrike KutayAbstract Heterogeneous nuclear ribonucleoproteins (hnRNPs)
are thought to be involved in pre-mRNA processing. hnRNP-
U, also termed scaﬀold attachment factor A (SAF-A), binds to
pre-mRNA and nuclear matrix/scaﬀold attachment region
DNA elements. However, its role in the regulation of gene
expression is as yet poorly understood. In the present study,
we show that hnRNP-U speciﬁcally enhances the expression of
tumor necrosis factor a mRNA by increasing its stability, possi-
bly through binding to the 3 0 untranslated region. We also show
that hnRNP-U enhances the expression of several other genes as
well, including GADD45A, HEXIM1, HOXA2, IER3,
NHLH2, and ZFY, by binding to and stabilizing these mRNAs.
These results suggest that hnRNP-U enhances the expression of
speciﬁc genes by regulating mRNA stability.
 2006 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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hnRNAs are primary transcription product of most of the
eukaryotic genes. They contain both exons and intronic se-
quences, and undergo a variety of processing events, including
5 0 capping, splicing, polyadenylation, and transport from the
nucleus. Heterogeneous nuclear ribonucleoprotein (hnRNP)
complexes were ﬁrst identiﬁed as major structural components
of chromatin-associated RNA-binding proteins. hnRNPs com-
prise a family of approximately 30 diﬀerent proteins, termed
hnRNP-A1 through-U, each of which possesses distinct
RNA-binding activity and RNA-binding preferences [1,2]. A
number of studies focusing on individual hnRNP proteins
have implicated hnRNPs in a variety of biological processes,
e.g., transcription, splicing, mRNA transport, recombination,
polyadenylation, mRNA turnover, control of translation,
and more [3].
hnRNP-U is a 120 kDa nuclear protein containing an argi-
nine- and glycine-rich region termed the RGG box in the
carboxy terminus, which is responsible for RNA binding [4].
hnRNP-U is also a major constituent of nuclear matrix orAbbreviations: hnRNP, heterogeneous nuclear ribonucleoprotein;
TNFa, tumor necrosis factor a; PMA, phorbol 12-myristate 13-acet-
ate; Q-PCR, quantitative polymerase chain reaction; UTR, untrans-
lated region; ARE, AU-rich element
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doi:10.1016/j.febslet.2006.11.062scaﬀold and is therefore termed scaﬀold attachment factor A
(SAF-A) [5]. It has been shown that hnRNP-U binds directly
to DNA sequences termed scaﬀold attachment regions
(SAR), and that this binding is mediated by the amino-termi-
nal acidic region [6]. Furthermore, hnRNP-U interacts with
and regulates various protein factors, such as transcriptional
coactivator p300, glucocorticoid receptor, Yes-associated pro-
tein (YAP), and the SCFb-TrCP ubiquitin ligase complex [7–10].
Mice carrying a hypomorphic mutation in the hnRNP-U gene
exhibit post-implantation lethality [11], suggesting that
hnRNP-U contributes to a variety of essential biological func-
tions, such as transcriptional regulation and RNA processing.
However, little is known about its exact role in the regulation
of gene expression.
In the present study, we demonstrate that hnRNP-U specif-
ically enhances tumor necrosis factor a (TNFa) mRNA
expression by stabilizing its mRNA. Using DNA microarray
analysis, we show that hnRNP-U enhances the expression of
several other genes as well, including HEXIM1, GADD45A,
HOXA2, IER3, NHLH2 and ZFY, by binding to and stabiliz-
ing these mRNAs. Our ﬁndings suggest that hnRNP-U en-
hances the expression of speciﬁc genes by regulating mRNA
stability.2. Materials and methods
2.1. Plasmids
To generate the mammalian expression vector of FLAG-hnRNP-U
(pcDNA3-FLAG-hnRNP-U), the cDNA for human hnRNP-U was
ampliﬁed by PCR and inserted into pcDNA3 containing the sequence
encoding FLAG peptide. The TNFa ORF and 3 0 untranslated region
(UTR) sequences were ampliﬁed by PCR and cloned into pBluescript
SK(+), resulting in pBS-ORF and pBS-30 UTR (872–1658), respec-
tively. To generate pBS-3 0 UTR (1088–1658), pBS-30 UTR (1295–
1658), and pBS-30 UTR (1529–1658), the 3 0 UTR fragment was di-
gested with EcoRI, NcoI, and SspI, respectively, and the resulting frag-
ments were inserted into pBluescript SK(+). pBS-U6-shRNA-hnRNP-
U was generated by inserting a double-stranded oligonucleotide down-
stream of the mouse U6 promoter of pBS-U6 so as to express the
following RNA: 5 0-GAUGAACACUUCGAUGACAuucaagagaUG-
UCAUCGAAGUGUUCAUCuu-3 0 [12].
2.2. Cell culture and transfection
Human embryonic kidney 293T cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium (Invitrogen) supplemented with 10% fetal
bovine serum (Sigma) in 5% CO2 at 37 C. Transfections were per-
formed using Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions.
2.3. Western blot analysis
293T cells were lysed with RIPA buﬀer (50 mM Tris–HCl, 150 mM
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS). Proteins
transferred to a PVDF membrane were probed with anti-FLAG M2blished by Elsevier B.V. All rights reserved.
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IjBa (Santa Cruz) antibody and were visualized using enhanced
chemiluminescence (Amersham).
2.4. Quantitative RT-PCR analysis
293T cells (1 · 106) were cultured in 35 mm dishes overnight and
then transfected with 4 lg of pcDNA3-FLAG, pcDNA3-FLAG-
hnRNP-U, pBS-U6, or pBS-U6-shRNA-hnRNP-U. Sixty hours later,
cells were treated with 50 nM phorbol 12-myristate 13-acetate (PMA)
and 1 lM A23187 for 2 h. For analysis of mRNA turnover, cells were
treated with 5 lg/ml actinomycin D for 0, 0.5, 1, 2, or 4 h, as indicated.
Total RNA was prepared using Sepasol Reagent (Nacalai) according
to the manufacturer’s instructions. First strand cDNA was synthesized
from 1 lg of total RNA using SuperScript III (Invitrogen) and oligo-
dT15 primer. PCR was performed using QuantiTect SYBR Green PCR
Master Mix (Qiagen) and an ABI 7300 real-time PCR system (Applied
Biosystems). PCR primers are shown in Supplementary Data.
2.5. Microarray analysis
RNA labeling and hybridization were carried out according the pro-
tocol provided by Aﬀymetrix. Brieﬂy, total RNA was isolated from
293T cells overexpressing or not expressing FLAG-hnRNP-U using
RNeasy kit (Qiagen), and 5 lg aliquots were used to prepare biotinyl-
ated cRNAs. Human Genome Focus Arrays (Aﬀymetrix), representing
8500 genes, were used. Array data were obtained in triplicate and ana-
lyzed using Microarray Analysis Suite 5.0.
2.6. In vivo RNA binding analysis
To examine the RNA binding activity of hnRNP-U in vivo, 293T
cells were transfected with pc-DNA3-FLAG-hnRNP-U, then lysed
with lysis buﬀer (25 mM Tris–HCl (pH 7.4) and 0.5% NP-40). Lysates
were incubated for 1 h at 4 C with 15 ll of anti-FLAG M2 agarose
(Sigma), yeast tRNA (2 mg/ml), and 200 U of RNase inhibitor (Pro-
mega). The samples were washed ﬁve times with wash buﬀer (50 mM
Tris–HCl, pH 7.4, 150 mM NaCl, 0.2 mM EDTA, and 0.5% NP-40),
and proteins were eluted with Laemmli buﬀer. Co-immunoprecipitat-
ing RNAs were extracted with phenol/chloroform, followed by ethanol
precipitation. The samples were treated with DNase I (Promega) and
analyzed by RT-PCR, followed by 2% agarose gel electrophoresis.
2.7. In vitro RNA binding analysis
RNA probes were generated by in vitro transcription using T3 RNA
polymerase and pBS-ORF or pBS-30UTR as template. 293T cells were
transfected with pcDNA3-FLAG-hnRNP-U, then lysed with lysis buf-
fer 2 (50 mM Tris–HCl, pH 7.9, 300 mMNaCl, 0.05% NP-40). Lysates
(10 ll) were incubated with yeast tRNA (0.2 mg/ml) at room tempera-
ture for 10 min. One of the 32P-labeled RNA probes (1 · 105 cpm) was
then added to the mixture, which was further incubated at room tem-
perature for 20 min. The reaction mixtures were exposed to UV light
for 10 min on ice, treated with RNase T1 (20U) at 37 C for 30 min,
and subjected to immunoprecipitation with 15 ll of anti-FLAG M2
agarose in 180 ll of RIPA buﬀer containing 500 mMNaCl. After incu-
bation at 4 C for 1 h, the samples were washed four times with RIPA
buﬀer containing 500 mM NaCl, and bound proteins were eluted with
Laemmli buﬀer, separated on a SDS–polyacrylamide gel, and sub-
jected to Western blotting and autoradiography.Fig. 1. hnRNP-U speciﬁcally enhances the expression of TNFa. (A)
293T cells were transfected with pcDNA3-FLAG-hnRNP-U or an
empty vector (mock). Cells lysates were subjected to Western blot
analysis using anti-hnRNP-U, anti-FLAG, and anti-actin antibodies.
(B) 293T cells were transfected with pcDNA3-FLAG-hnRNP-U or
mock-transfected, and 60 h later, cells were treated with or without
PMA and calcium ionophore (P/I) for 2 h. Total RNA was prepared
and analyzed by reverse transcription Q-PCR using primers speciﬁc for
the indicated mRNAs. The data represent the average ± standard
deviation (S.D.) of three independent experiments. **, P < 0.01. (C)
293T cells were processed as in (B) and subjected to Western blot
analysis using anti-hnRNP-U, anti-IjBa, and anti-actin antibodies.3. Results
3.1. hnRNP-U speciﬁcally enhances the expression of TNFa
It was previously reported that hnRNP-U regulates the
SCFb-TrCP ubiquitin ligase complex by acting as a pseudosub-
strate [10]. The SCFb-TrCP complex recognizes and degrades
various substrates, such as IjBa, b-catenin, and PDCD4
through a proteasome-mediated degradation pathway in the
nucleus [10,13,14]. Since these results suggested that hnRNP-
U may be involved in transcriptional regulation by the NF-
jB pathway, we ﬁrst examined whether hnRNP-U aﬀects the
expression of several genes known to be regulated by NF-jB, namely TNFa, A20, IjBa, and SDC4 [15,16]. We ex-
pressed FLAG-tagged hnRNP-U (FLAG-hnRNP-U) in
293T cells, with or without treatment of PMA and the calcium
ionophore A23187, and examined the mRNA levels using re-
verse transcription quantitative polymerase chain reaction
(Q-PCR). The level of ectopically expressed FLAG-hnRNP-
U was approximately two-times higher than that of endo-
genous hnRNP-U (Fig. 1A). The TNFa mRNA level was
increased by overexpression of FLAG-hnRNP-U, irrespective
of the presence of PMA and calcium ionophore (Fig. 1B). In
particular, the basal level of TNFa was increased approxi-
mately 12-fold by FLAG-hnRNP-U overexpression. By con-
trast, FLAG-hnRNP-U did not appreciably aﬀect the levels
of A20, IjBa, SDC4, and control GAPDH (Fig. 1B and C).
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TNFa gene expression independently of transcriptional activa-
tion via the NF-jB pathway.
To verify the speciﬁcity of hnRNP-U on TNFa gene expres-
sion, we employed RNAi targeting endogenous hnRNP-U.
The level of endogenous hnRNP-U in 293T cells was speciﬁ-
cally decreased by transfection with an expression vector
encoding a short-hairpin RNA (shRNA) speciﬁc for hnRNP-
U (Fig. 2A). Furthermore, knockdown of hnRNP-U resulted
in a reduction in the level of TNFa gene expression induced
by PMA and calcium ionophore but did not aﬀect the expres-
sion of several other genes (Fig. 2B), which is consistent with
the above ﬁnding. No such eﬀect was observed when an empty
vector or a vector expressing an irrelevant shRNA was used in-B
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Fig. 2. Knockdown analysis of hnRNP-U-mediated regulation of gene
expression (A) 293T cells were transfected with an expression vector
encoding an hnRNP-speciﬁc shRNA, pBS-U6-shRNA-hnRNP-U, or
an empty vector (mock). Cells were lysed and subjected to Western
blot analysis using anti-hnRNP-U and anti-actin antibodies. (B) 293T
cells were transfected with pBS-U6-shRNA-hnRNP-U or mock-
transfected, and 60 h later, the cells were treated with or without
PMA and calcium ionophore (P/I) for 2 h. Total RNA was prepared
and analyzed by reverse transcription Q-PCR using primers speciﬁc for
the indicated mRNAs. The data represent the average ± S.D. of three
independent experiments. **, P < 0.01.stead (Fig. 2B and data not shown). These results conﬁrmed
that hnRNP-U speciﬁcally regulates TNFa gene expression.
3.2. hnRNP-U stabilizes TNFa mRNA
We next examined the eﬀect of hnRNP-U on TNFa mRNA
turnover. The half-life of TNFamRNA in 293T cells following
PMA and ionophore treatment was measured by pulsing the
cells with actinomycin D for various times and analyzing the70
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Fig. 3. hnRNP-U stabilizes TNFa mRNA 293T cells were transfected
with an empty vector or pcDNA3-FLAG-hnRNP-U, then treated with
PMA and calcium ionophore for 2 h. The cells were also treated with
5 lg/ml actinomycin D for the indicated times, after which total RNA
was prepared and analyzed by reverse transcription Q-PCR using
primers speciﬁc for TNFa (A), A20 (B) and GAPDH (C) mRNAs.
mRNA accumulation was normalized to the level at time point t = 0.
The mRNA levels of mock-transfected cells and FLAG-hnRNP-U-
transfected cells are indicated by squares and triangles, respectively.
The data obtained from three independent experiments were ﬁtted to
exponential decay curves.
Table 1
Genes upregulated with hnRNP-U overexpression
Probe set ID RefSeq Symbol Gene name Fold changea
202284_s_at NM_000389 CDKN1A Cyclin-dependent kinase inhibitor 1A 2.95
206515_at NM_000896 CYP4E3 Cytochrome P450, subfamily IVF, polypeptide 3 (leukotriene B4 omega hydroxylase) 3.61
203725_at NM_001924 GADD45A Growth arrest and DNA-damage-inducible, alpha (GADD45A) 2.39
202814_s_at NM_006460 HEXIM1 HMBA-inducible 1(HEXIM1) 2.25
214457_at NM_006735 HOXA2 homeo box A2 3.53
201631_s_at NM_003897 IER3 immediate early response 3 2.28
211371_at U71088 MEK5c MAP kinase kinase MEK5c 8.17
215228_at AA166895 NHLH2 Nescient helix loop helix 2 3.94
220623_s_at NM_025244 TSGA10 Testis speciﬁc, 10 2.83
207247_s_at NM_003411 ZFY Zinc ﬁnger protein, Y-linked 10.93
Boldface genes were validated by quantitative PCR.
aAverage fold change; hnRNP-U overexpressed vs. mock.
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Fig. 4. hnRNP-U enhances the expression of speciﬁc genes (A) 293T cells were transfected with pcDNA3-FLAG-hnRNP-U or an empty vector
(mock). Total RNA was prepared and analyzed by reverse transcription Q-PCR using primers speciﬁc for the indicated mRNAs. The data represent
the average ± S.D. of three independent experiments. **, P < 0.01; *, P < 0.05. (B) 293T cells were transfected with an empty vector (mock) or
pcDNA3-FLAG-hnRNP-U, and 60 h later, the cells were treated with 5 lg/ml actinomycin D for the indicated times. Total RNA was prepared and
analyzed by reverse transcription Q-PCR. The data represent the average of three independent experiments.
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estimated to be approximately 45 min (Fig. 3A). Overexpres-
sion of FLAG-hnRNP-U signiﬁcantly enhanced TNFa
mRNA stability, increasing its half-life to approximately
90 min. In contrast, turnover of A20 or GAPDH mRNA
was not appreciably aﬀected by overexpression of hnRNP-U
(Fig. 3B and C). These results suggested that hnRNP-U specif-
ically stabilizes TNFa mRNA.
3.3. hnRNP-U regulates the expression of a subset of genes by
stabilizing mRNA
We next analyzed the gene expression proﬁle of 293T cells in
the presence or absence of ectopic FLAG-hnRNP-U overex-
pression using DNA microarray analysis. Array data were ob-
tained in triplicate, and genes whose expression levels change
over two-fold were selected. Of 8500 genes analyzed, 10 genes
were found to be upregulated by hnRNP-U overexpression
(Table 1). TNFa was not found in the list, because the mRNA
level was too low to be detected by microarray analysis. Q-
PCR analysis conﬁrmed that overexpression of hnRNP-U in-
deed signiﬁcantly enhanced the expression of GADD45A,
HEXIM1, HOXA2, IER3, NHLH2 and ZFY (Fig. 4A).
Moreover, mRNAs of these genes were stabilized by
hnRNP-U, as in the case of TNFa mRNA (Fig. 4B). These re-
sults suggested that hnRNP-U enhances the expression of a
subset of genes by stabilizing mRNA.
3.4. hnRNP-U recognizes speciﬁc mRNAs
We next examined whether hnRNP-U associates with these
mRNAs in vivo. FLAG-hnRNP-U was transiently expressed
in 293T cells and immunoprecipitated using anti-FLAG orFig. 5. hnRNP-U recognizes speciﬁc mRNAs 293T cells were trans-
fected with pcDNA3-FLAG-hnRNP-U, then subjected to immuno-
precipitation using anti-FLAG (lane 2) or control anti-V5 (lane 3)
antibody. Co-immunoprecipitating mRNAs as well as 25% of the total
RNA used (lane 1) were analyzed by RT-PCR.control anti-V5 antibody. Co-immunoprecipitating RNA was
then analyzed by RT-PCR. TNFa, GADD45A, HEXIM1,
HOXA2, IER3, NHLH2, and ZFY mRNAs, which were spe-
ciﬁcally upregulated by hnRNP-U, were recovered in anti-
FLAG immunoprecipitates, while A20 and SDC4 mRNAs
were not (Fig. 5). These results suggested that hnRNP-U spe-
ciﬁcally recognizes its target mRNAs.
3.5. hnRNP-U binds directly to 3 0 UTR of TNFa mRNA
To map the region of TNFamRNA responsible for hnRNP-
U binding, we performed UV crosslinking experiments using
RNA probes corresponding to the ORF and the 3 0 UTR re-
gion of TNFa mRNA (Fig. 6). Crude extracts from 293T cells
expressing FLAG-hnRNP-U were subjected to UV crosslink-
ing with one of the RNA probes, and following RNase T1
treatment, FLAG-hnRNP-U was immunoprecipitated and
analyzed. hnRNP-U bound to the 3 0 UTR region but not to
the ORF region (Fig. 6C, lanes 1 and 2). The 3 0 half (nucleo-
tide positions 1295–1658) of the 3 0 UTR was found to be
important for hnRNP-U binding (lanes 3–8).4. Discussion
In this study, we showed that hnRNP-U regulates the
expression of TNFa and a speciﬁc subset of genes by stabiliz-
ing mRNA. This function is not dependent on hnRNP-U bind-
ing to the SCFb-TrCP ubiquitin ligase complex but appears to
be mediated by its binding to the 3 0 UTRs of target mRNAs,
and therefore, probably represents a new role of hnRNP-U.
We showed that overexpression of hnRNP-U increased the
level of TNFa mRNA both before and after induction with
PMA and calcium ionophore (Fig. 1B). On the other hand,
knockdown of hnRNP-U decreased the level of TNFa mRNA
only after induction (Fig. 2B). Why was then the basal level of
TNFa not aﬀected by hnRNP-U depletion? We think that
hnRNP-U activity is regulated during PMA/calcium iono-
phore induction. According to our model, after induction,
hnRNP-U is in an active form, contributing to the stabilization
and high-level expression of TNFa mRNA, and therefore,
overexpression or knockdown of hnRNP-U results in either
up- or down-regulation of TNFa mRNA. On the other hand,
hnRNP-U may normally be in an inactive state before induc-
tion. Given this assumption, hnRNP-U knockdown does not
aﬀect the TNFa mRNA level, while hnRNP-U overexpression
may change the equilibrium between active and inactive states,
leading to strong enhancement of TNFa mRNA expression.
This idea is shown to be the case for hnRNP-A1, a member
of the large hnRNP family with limited homology to
hnRNP-U [4]. Previously, hnRNP-A1 was shown to bind to
TNFa mRNA only after activation of T cells [17]. hnRNP-
A1 activity appears to be controlled through its phosphoryla-
tion by the protein kinases called Mnks, which occurs during T
cell activation [17]. As for hnRNP-U, its activity may be con-
trolled by phosphorylation, as found in hnRNP-A1, or by
competitively acting mRNA destabilizing factors.
We showed the hnRNP-U is associated with the target
mRNAs in vivo (Fig. 5). Moreover, in vitro UV crosslinking
study showed that hnRNP-U directly binds to a 364 nt region
within the 3 0 UTR of TNFa mRNA (Fig. 6). The 3 0 region
contains an AU-rich element (ARE), a mRNA destabilizing
element that is bound by several ARE-binding proteins
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(1 · 105 cpm) and subjected to UV crosslinking, RNase treatment, and immunoprecipitation with anti-FLAGM2 antibody. The immunoprecipitants
were analyzed on a SDS–polyacrylamide gel followed by autoradiography and Western blot analysis using anti-FLAG antibody.
6 M. Yugami et al. / FEBS Letters 581 (2007) 1–7(AUBPs) [18]. Besides, according to the human AU-rich ele-
ment-containing database ARED3.0 [19], many of the genes
identiﬁed in the microarray screen, such as HEXIM1, ZFY,
NHLH2, and IER3, have potential AREs. GADD45A has
been reported to have a long AU-rich 3 0UTR, to which
AUBPs bind [20]. Although HOXA2 was neither listed in
the database nor reported, it also has ARE-like sequences.
Hence, AREs may be involved in the regulation by hnRNP-
U. However, since the 3 0 UTR fragment (spanning nucleotide
positions 872–1528) containing the ARE was not eﬃciently
bound by hnRNP-U (Fig. 6), it is very likely that additional
sequence elements in the 3 0 UTR are also involved in the
hnRNP-U action. hnRNP-U has been reported to bind prefer-
entially to poly(G), poly(U) [4], and leader sequence RNA
(LS-RNA) of vesicular stomatitis virus [21]. Although we
examined the 3 0 UTR sequence of TNFa extensively, we could
not ﬁnd any homology to LS-RNA. Also, there was no appar-
ent correlation between G/U content and hnRNP-U binding,
i.e., clusters of G and U were found in both the TNFa
ORF, to which hnRNP-U does not bind, and the 3 0 UTR,to which hnRNP-U binds, to a similar extent. Understanding
the mechanism by which hnRNP-U speciﬁcally recognizes tar-
get mRNAs and controls their stability remains the subject of
further studies.
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